57894-651 : Tremfya 200 mg/2ml Subcutaneous Injection
NDC: | 57894-651 |
Labeler: | Janssen Biotech, Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | Tremfya |
Dosage Form: | Subcutaneous Injection |
Application #: | BLA761061 |
Rev. Date: |
NDC Package Codes:
- 57894-651-02: 1 SYRINGE IN 1 CARTON (57894‑651‑02) / 2 ML IN 1 SYRINGE (57894‑651‑01)
- 57894-651-22: 1 SYRINGE IN 1 CARTON (57894‑651‑22) / 2 ML IN 1 SYRINGE (57894‑651‑11)
- 57894-651-92: 1 SYRINGE IN 1 CARTON (57894‑651‑92) / 2 ML IN 1 SYRINGE (57894‑651‑99)
Active Ingredients:
- Guselkumab
Dosage Strength:
- 200 mg/2mL
Pharmaceutical Classes:
- Interleukin-23 Antagonist [EPC]
- Interleukin-23 Antagonists [MoA]
Related Products:
Based on records with the same trade name.- 57894-640 Tremfya 100 mg/ml Subcutaneous Injection by Janssen Biotech, Inc.
- 57894-650 Tremfya 200 mg/20ml Intravenous Injection by Janssen Biotech, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 57894-650Next: 57896-101 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.